Precision Medicine: Where have we reached and where are we headed?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. A Preliminary Association Study of H19 Non-Coding Gene Variants With Risk of Non-Hodgkin Lymphoma: A Case-Control Study and Computational Analysis.Journal of clinical laboratory analysis · 2025
   Article
2. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.Cancer cell international · 2023
   Review
3. Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring.Journal of clinical medicine · 2023
   Review
4. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.Frontiers in medicine · 2022
   Review
5. Integration strategies of multi-omics data for machine learning analysis.Computational and structural biotechnology journal · 2021
   Review
6. Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines.International journal of molecular sciences · 2020
   Article
7. Patient-derived xenograft models for personalized medicine in colorectal cancer.Clinical and experimental medicine · 2020
   Review
8. Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.Oncology reports · 2018
   Article
9. The growing role of precision and personalized medicine for cancer treatment.Technology
   Article
10. Developing a Discrete Choice Experiment Instrument for Evaluating Patients' Preferences in Precision Oncology.Iranian journal of pharmaceutical research : IJPR
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as